Global Long-Read Sequencing Market Growth (Status and Outlook) 2024-2030
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
The global Long-Read Sequencing market size is projected to grow from US$ 696 million in 2024 to US$ 2342 million in 2030; it is expected to grow at a CAGR of 22.4% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Long-Read Sequencing Industry Forecast” looks at past sales and reviews total world Long-Read Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Long-Read Sequencing sales for 2023 through 2029. With Long-Read Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Read Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Long-Read Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-Read Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Read Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Read Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Read Sequencing.
United States market for Long-Read Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Long-Read Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Long-Read Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Long-Read Sequencing players cover Oxford Nanopore, Agilent Technologies, Thermo Fisher Scientific, QIAGEN, PacBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Read Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nanopore Sequencing
Single-molecule Real-time Sequencing
Synthetic Long-read Sequencing
Segmentation by Application:
Research Institutes
Hospitals
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Nanopore Sequencing
Single-molecule Real-time Sequencing
Synthetic Long-read Sequencing
Segmentation by Application:
Research Institutes
Hospitals
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Oxford Nanopore
Agilent Technologies
Thermo Fisher Scientific
QIAGEN
PacBio
Illumina
Takara Bio
10X Genomics
Danaher
Azenta US
Revvity
New England Biolabs
BaseClear
Element Biosciences
CD Genomics
Sage Sciences
EdenRoc Sciences
BGI Group
Novogene
Grandomics
Wuhan Beina Technology
Please note: The report will take approximately 2 business days to prepare and deliver.